These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38961395)

  • 1. Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy.
    Kalra J; Baker J; Sun X; Kyle A; Minchinton A; Bally MB
    J Transl Med; 2024 Jul; 22(1):621. PubMed ID: 38961395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model.
    Kalra J; Baker J; Song J; Kyle A; Minchinton A; Bally M
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34199298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection.
    Marazioti A; Papadia K; Giannou A; Stathopoulos GT; Antimisiaris SG
    Int J Nanomedicine; 2019; 14():3773-3784. PubMed ID: 31213801
    [No Abstract]   [Full Text] [Related]  

  • 4. High-resolution 3D visualization of nanomedicine distribution in tumors.
    Moss JI; Barjat H; Emmas SA; Strittmatter N; Maynard J; Goodwin RJA; Storm G; Lammers T; Puri S; Ashford MB; Barry ST
    Theranostics; 2020; 10(2):880-897. PubMed ID: 31903157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models.
    Ito K; Hamamichi S; Asano M; Hori Y; Matsui J; Iwata M; Funahashi Y; Umeda IO; Fujii H
    Cancer Sci; 2016 Jan; 107(1):60-7. PubMed ID: 26509883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
    Sine J; Urban C; Thayer D; Charron H; Valim N; Tata DB; Schiff R; Blumenthal R; Joshi A; Puri A
    Int J Nanomedicine; 2015; 10():125-45. PubMed ID: 25565809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment.
    Baker JHE; Kyle AH; Reinsberg SA; Moosvi F; Patrick HM; Cran J; Saatchi K; Häfeli U; Minchinton AI
    Clin Exp Metastasis; 2018 Oct; 35(7):691-705. PubMed ID: 30196384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
    Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles target early-stage breast cancer metastasis in vivo.
    Goldman E; Zinger A; da Silva D; Yaari Z; Kajal A; Vardi-Oknin D; Goldfeder M; Schroeder JE; Shainsky-Roitman J; Hershkovitz D; Schroeder A
    Nanotechnology; 2017 Oct; 28(43):43LT01. PubMed ID: 28872058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and therapeutic efficacy of HER2 scFv-targeted liposomal doxorubicin in a murine model of HER2-overexpressing breast cancer.
    Laginha KM; Moase EH; Yu N; Huang A; Allen TM
    J Drug Target; 2008 Aug; 16(7):605-10. PubMed ID: 18686132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.
    Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF
    J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.
    Kibria G; Hatakeyama H; Sato Y; Harashima H
    Int J Pharm; 2016 Jul; 509(1-2):178-187. PubMed ID: 27234700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.
    Kroon J; Buijs JT; van der Horst G; Cheung H; van der Mark M; van Bloois L; Rizzo LY; Lammers T; Pelger RC; Storm G; van der Pluijm G; Metselaar JM
    Prostate; 2015 Jun; 75(8):815-24. PubMed ID: 25663076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
    Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
    Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
    Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
    J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
    Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
    Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.